Discover 1,068 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,068
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: West Valley City UT, West Jordan UT, Meridian ID,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase3, Recruiting
Active & Responsive
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
for
Geographic Atrophy, Macular Degeneration
Location: Salt Lake City UT, Murray UT, Lakewood CO, Aurora CO,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 0+
Code: NCT06779773
Recruiting
Active & Responsive
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer,
Location: West Valley City UT, Scottsdale AZ, Rochester MN,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07361562
Phase1, Recruiting
Active & Responsive
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours
for
Advanced Solid Tumor
Location: West Valley City UT, Dallas TX, Grand Rapids MI,
Sponsor: Ipsen
Sex: All
Age: 18+
Code: NCT06833008
Phase1, Phase2, Recruiting
Active & Responsive
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: West Valley City UT, Santa Rosa CA, Seattle WA,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07277413
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
for
Castration-Resistant Prostate Cancer (CRPC),
Location: West Valley City UT, Los Angeles CA, Omaha NE,
Sponsor: Monte Rosa Therapeutics, Inc
Sex: Male
Age: 18+
Code: NCT07745361
Phase2, Recruiting
Active & Responsive
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
for
Colorectal Cancer
Location: West Valley City UT, Los Angeles CA, Seattle WA,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659795
Phase2, Recruiting
Active & Responsive
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: West Valley City UT, San Francisco CA, Irving TX,
Sponsor: MBrace Therapeutics
Sex: All
Age: 18+
Code: NCT07145255
Phase1, Phase2, Recruiting
Active & Responsive
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: West Valley City UT, Omaha NE, Dallas TX,
Sponsor: Tasca Therapeutics
Sex: All
Age: 18+
Code: NCT07030257
Phase1, Phase2, Recruiting
Active & Responsive
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
for
Breast Cancer, Endometrial Cancer, Ovarian Cancer,
Location: West Valley City UT, Duarte CA, Irvine CA, Omaha NE,
Sponsor: Terremoto Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07109726
Phase1, Phase2, Recruiting
Active & Responsive
A Study of RSLV-132 in Females With Sjögren's Disease
for
Primary Sjögren Syndrome
Location: Salt Lake City UT, Albuquerque NM, Spokane WA,
Sponsor: Resolve Therapeutics
Sex: Female
Age: 18 - 70+
Code: NCT06440525
Phase2, Recruiting
Active & Responsive
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia (ITP),
Location: Salt Lake City UT, Billings MT, Sioux Falls SD,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07421167
Phase2, Recruiting
Active & Responsive
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Salt Lake City UT, Bakersfield CA, Cerritos CA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT06901531
Phase3, Recruiting
Active & Responsive
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Salt Lake City UT, Albuquerque NM, Santa Rosa CA,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase1, Phase2, Recruiting
Active & Responsive
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
for
Colorectal Cancer
Location: Salt Lake City UT, Fountain Valley CA, Seattle WA,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05234177
Recruiting
Active & Responsive
A Phase 1, First-in-human Study of VX-433
for
Narcolepsy Type 1 (NT1)
Location: Salt Lake City UT
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 55
Code: NCT07584434
Phase1, Recruiting
Active & Responsive
A Study of LY4088044 in Healthy Participants
for
Healthy
Location: Salt Lake City UT, Los Alamitos CA, San Antonio TX
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07090785
Phase1, Recruiting
Active & Responsive
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
for
Weight Management
Location: Salt Lake City UT, San Antonio TX, Miami FL
Sponsor: Gilead Sciences
Sex: All
Age: 18 - 55
Code: NCT06562907
Phase1, Recruiting
Active & Responsive
Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)
for
Pelizaeus-Merzbacher Disease
Location: Salt Lake City UT, Atlanta GA, Philadelphia PA
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: Male
Age: 2 - 17
Code: NCT06150716
Phase1, Recruiting
Active & Responsive
A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)